This content is machine translated Osteoporosis Risk-stratified therapy with osteoanabolic agents improves outcomes Patients with a very high or imminent fracture risk should be considered for (first-line) therapy with ostoanabolic substances. Both patient selection and planning of therapy sequences are decisive factors for...…
